Sign up for free.
Abaxis, Inc., now part of Zoetis, is an innovative company in the field of point-of-care blood chemistry diagnostics. The company is dedicated to the development and distribution of fast, precise, and reliable analyzers that enable medical professionals to make diagnoses and create treatment plans in real time.
The core product of Abaxis is the Piccolo Xpress® Chemistry Analyzer. This system allows medical professionals to perform comprehensive multi-chemistry panels with just a few drops of whole blood, serum, or plasma. The patented system uses disposable reagent discs that can contain up to 31 specific tests. The Piccolo Xpress® delivers results in approximately 12 minutes, providing a fast and efficient solution for point-of-care diagnostics.
Abaxis serves a wide range of medical facilities, including doctor's offices, emergency rooms, hospitals, specialty clinics, as well as government and military facilities. The company is committed to improving patient care by empowering medical professionals to make faster and more informed decisions.
The mission of Abaxis is to develop innovative diagnostic solutions that increase efficiency, increase patient satisfaction, and improve clinical outcomes. The company values accuracy, reliability, and ease of use of its products.
Although the information provided does not mention explicit sustainability goals, it is likely that Abaxis, as part of Zoetis, feels committed to the sustainability initiatives of the parent company. Zoetis is committed to responsible business practices and environmental protection. This could be reflected in Abaxis' production processes, material sourcing, and waste management. For more detailed information on sustainability efforts, it is recommended to visit the Zoetis website.
Abaxis, Inc. has established itself as a leading provider of point-of-care diagnostics and helps to improve healthcare worldwide.
